ArticleCurrent oncology (Toronto, Ont.)2022

Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma.

Randeep Sangha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.